Evidence map›Paper›PMID 25065697›Full record

ArticleAddiction biology2015

Effect of yohimbine on reinstatement of operant responding in rats is dependent on cue contingency but not food reward history.

Yu-Wei Chen, Kimberly A Fiscella, Samuel Z Bacharach, Gianluigi Tanda, Yavin Shaham, Donna J Calu

Abstract read
In one paragraph

Article in Addiction biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. The anxiogenic drug yohimbine is a reinforcer in male and female rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  7. Multifaced Nature of Yohimbine-A Promising Therapeutic Potential or a Risk?International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Activation of peroxisome proliferator-activated receptor γ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yu-Wei ChenBehavioral Neuroscience Research Branch, NIDA, NIH, DHHS, Baltimore, MD, USA.
Kimberly A FiscellaBehavioral Neuroscience Research Branch, NIDA, NIH, DHHS, Baltimore, MD, USA.
Samuel Z BacharachBehavioral Neuroscience Research Branch, NIDA, NIH, DHHS, Baltimore, MD, USA.
Gianluigi TandaMedication Development Program, Intramural Research Program, NIDA, NIH, DHHS, Baltimore, MD, USA.
Yavin ShahamBehavioral Neuroscience Research Branch, NIDA, NIH, DHHS, Baltimore, MD, USA.
Donna J CaluBehavioral Neuroscience Research Branch, NIDA, NIH, DHHS, Baltimore, MD, USA.
Behavioral Pharma (United States) · USUnited States Department of Health and Human Services · US

Funding

Neurobiology Of Relapse To Opiate and Psychostimulant DrugsZIADA000434 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI SHAHAM, YAVIN · 2009 to 2025
$39.8M
Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

Yohimbine is an alpha-2 adrenoceptor antagonist that has been used in numerous studies as a pharmacological stressor in rodents, monkeys and humans. Recently, yohimbine has become the most common stress manipulation in studies on reinstatement of drug and food seeking. However, the wide range of conditions under which yohimbine promotes reward seeking is significantly greater than that of stressors like intermittent footshock. Here, we addressed two fundamental questions regarding yohimbine's effect on reinstatement of reward seeking: (1) whether the drug's effect on operant responding is dependent on previous reward history or cue contingency, and (2) whether yohimbine is aversive or rewarding under conditions typically used in reinstatement studies. We also used in vivo microdialysis to determine yohimbine's effect on dopamine levels in nucleus accumbens (NAc) and medial prefrontal cortex (mPFC). We found that the magnitude of yohimbine-induced (0.5, 1.0, 2.0 mg/kg) operant responding during the reinstatement tests was critically dependent on the contingency between lever pressing and discrete tone-light cue delivery but not the previous history with food reward during training. We also found that yohimbine (2 mg/kg) did not cause conditioned place aversion. Finally, we found that yohimbine modestly increased dopamine levels in mPFC but not NAc. Results suggest that yohimbine's effects on operant responding in reinstatement studies are likely independent of the history of contingent self-administration of food or drug rewards and may not be related to the commonly assumed stress-like effects of yohimbine.

Indexed as

CuesReinforcement, PsychologyRewardAdrenergic alpha-2 Receptor AntagonistsAnalysis of VarianceAnimalsCentral Nervous System StimulantsConditioning, OperantDopamineExtinction, PsychologicalFoodMaleMethamphetamineMotor ActivityRats, Long-EvansYohimbineAdrenergic alpha-2 Receptor AntagonistsCentral Nervous System StimulantsDopamineMethamphetamineYohimbineConditioned place preference/aversiondopaminereinstatementsensory seekingstressyohimbine

Identifiers

PMID25065697
PMCPMC4308573
OpenAlexW1901230144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.